November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Hope Rugo: Important work on HR+ disease by Laura Huppert
Oct 31, 2024, 14:58

Hope Rugo: Important work on HR+ disease by Laura Huppert

Hope Rugo, Professor of medicine at the University of California San Francisco, shared an article on X:

“Congratulations Laura Huppert!

Important work HR+ disease. pCR rates for patients with HR+/HER2- high-risk, EBC by clinical and molecular features in the phase II I-SPY2 clinical trial – Annals of Oncology.”

Pathologic complete response (pCR) rates for patients with HR+/HER2- high-risk, early-stage breast cancer (EBC) by clinical and molecular features in the phase II I-SPY2 clinical trial.

Authors: Laura Huppert, et al.

Hope Rugo: Important work on HR+ disease by Laura Huppert

Dr. Hope Rugo, is a professor of medicine at the University of California San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center. With experience in hematology and oncology, she specializes in breast cancer treatment and clinical trials. Dr. Rugo’s research focuses on innovative therapies and combination treatments to improve outcomes for breast cancer patients, including immunotherapy and targeted agents. She is known for her contributions to reducing treatment toxicity educating through initiatives like the Breast Forum.